These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36050498)

  • 1. Docking study, molecular dynamic, synthesis, anti-α-glucosidase assessment, and ADMET prediction of new benzimidazole-Schiff base derivatives.
    Azizian H; Pedrood K; Moazzam A; Valizadeh Y; Khavaninzadeh K; Zamani A; Mohammadi-Khanaposhtani M; Mojtabavi S; Faramarzi MA; Hosseini S; Sarrafi Y; Adibi H; Larijani B; Rastegar H; Mahdavi M
    Sci Rep; 2022 Sep; 12(1):14870. PubMed ID: 36050498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro alpha-glucosidase inhibitory potential of benzimidazole bearing bis-Schiff bases and their molecular docking study.
    Rahim F; Zaman K; Taha M; Ullah H; Ghufran M; Wadood A; Rehman W; Uddin N; Shah SAA; Sajid M; Nawaz F; Khan KM
    Bioorg Chem; 2020 Jan; 94():103394. PubMed ID: 31699396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, in vitro α-glucosidase inhibition, docking, and molecular dynamics of new phthalimide-benzenesulfonamide hybrids for targeting type 2 diabetes.
    Askarzadeh M; Azizian H; Adib M; Mohammadi-Khanaposhtani M; Mojtabavi S; Faramarzi MA; Sajjadi-Jazi SM; Larijani B; Hamedifar H; Mahdavi M
    Sci Rep; 2022 Jun; 12(1):10569. PubMed ID: 35732907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
    Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M
    Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.
    Asemanipoor N; Mohammadi-Khanaposhtani M; Moradi S; Vahidi M; Asadi M; Faramarzi MA; Mahdavi M; Biglar M; Larijani B; Hamedifar H; Hajimiri MH
    Bioorg Chem; 2020 Jan; 95():103482. PubMed ID: 31838286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isatin based Schiff bases as inhibitors of α-glucosidase: Synthesis, characterization, in vitro evaluation and molecular docking studies.
    Rahim F; Malik F; Ullah H; Wadood A; Khan F; Javid MT; Taha M; Rehman W; Ur Rehman A; Khan KM
    Bioorg Chem; 2015 Jun; 60():42-8. PubMed ID: 25955493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship studies of benzimidazole-thioquinoline derivatives as α-glucosidase inhibitors.
    Moghadam Farid S; Noori M; Nazari Montazer M; Khalili Ghomi M; Mollazadeh M; Dastyafteh N; Irajie C; Zomorodian K; Mirfazli SS; Mojtabavi S; Faramarzi MA; Larijani B; Iraji A; Mahdavi M
    Sci Rep; 2023 Mar; 13(1):4392. PubMed ID: 36928433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, in vitro, and in silico enzymatic evaluations of thieno[2,3-b]quinoline-hydrazones as novel inhibitors for α-glucosidase.
    Noori M; Rastak M; Halimi M; Ghomi MK; Mollazadeh M; Mohammadi-Khanaposhtani M; Sayahi MH; Rezaei Z; Mojtabavi S; Ali Faramarzi M; Larijani B; Biglar M; Amanlou M; Mahdavi M
    Bioorg Chem; 2022 Oct; 127():105996. PubMed ID: 35878449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, in vitro, and in silico evaluations of benzo[d]imidazole-amide-1,2,3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting α-glucosidase.
    Yousefnejad F; Mohammadi-Moghadam-Goozali M; Sayahi MH; Halimi M; Moazzam A; Mohammadi-Khanaposhtani M; Mojtabavi S; Asadi M; Faramarzi MA; Larijani B; Amanlou M; Mahdavi M
    Sci Rep; 2023 Jul; 13(1):12397. PubMed ID: 37524733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and molecular modelling of bis-Schiff base derivatives as potential leads for management of diabetes mellitus.
    Daoud S; Thiab S; Jazzazi TMA; Al-Shboul TMA; Ullah S
    Acta Pharm; 2022 Sep; 72(3):449-458. PubMed ID: 36651543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrano[2,3-b]chromone derivatives as novel dual inhibitors of α-glucosidase and α-amylase: Design, synthesis, biological evaluation, and in silico studies.
    Farzaneh E; Mohammadi M; Raymand P; Noori M; Golestani S; Ranjbar S; Ghasemi Y; Mohammadi-Khanaposhtani M; Asadi M; Nasli Esfahani E; Rastegar H; Larijani B; Mahdavi M; Taslimi P
    Bioorg Chem; 2024 Apr; 145():107207. PubMed ID: 38402795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of new phenoxymethylcoumarin clubbed 4-arylthiazolylhydrazines as α-glucosidase inhibitors and their kinetics and molecular docking studies.
    Ul Ain Q; Saeed A; Khan A; Ahmed A; Ullah S; Ahsan Halim S; Irfan M; Tehzeeb A; El-Seedi HR; Bin Muhsinah A; Al-Harrasi A
    Bioorg Chem; 2023 Feb; 131():106302. PubMed ID: 36528921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl-quinoline-4-carbonyl hydrazone bearing different 2-methoxyphenoxyacetamides as potent α-glucosidase inhibitors; molecular dynamics, kinetic and structure-activity relationship studies.
    Hamedifar H; Mirfattahi M; Khalili Ghomi M; Azizian H; Iraji A; Noori M; Moazzam A; Dastyafteh N; Nokhbehzaim A; Mehrpour K; Javanshir S; Mojtabavi S; Faramarzi MA; Larijani B; Hajimiri MH; Mahdavi M
    Sci Rep; 2024 Jan; 14(1):388. PubMed ID: 38172167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Amide-Functionalized Benzimidazolium Salts as Potent α-Glucosidase Inhibitors.
    Khan IA; Ahmad M; Ashfaq UA; Sultan S; Zaki MEA
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, molecular docking study, and α-glucosidase inhibitory evaluation of novel hydrazide-hydrazone derivatives of 3,4-dihydroxyphenylacetic acid.
    Khan H; Jan F; Shakoor A; Khan A; AlAsmari AF; Alasmari F; Ullah S; Al-Harrasi A; Khan M; Ali S
    Sci Rep; 2024 May; 14(1):11410. PubMed ID: 38762658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coumarin linked to 2-phenylbenzimidazole derivatives as potent α-glucosidase inhibitors.
    Ganjeh MS; Mazlomifar A; Shahvelayti AS; Moghaddam SK
    Sci Rep; 2024 Mar; 14(1):7408. PubMed ID: 38548784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Bis-Schiff's base derivatives of 4-nitroacetophenone as potent α-glucosidase agents: Design, synthesis and in silico approach.
    Alam A; Ali M; Latif A; Rehman NU; Saher S; Zainab ; Faryal ; Khan A; Ullah S; Ullah O; Halim SA; Sani F; Al-Harrasi A; Ahmad M
    Bioorg Chem; 2022 Nov; 128():106058. PubMed ID: 35917750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
    Ullah H; Khan S; Rahim F; Taha M; Iqbal R; Sarfraz M; Shah SAA; Sajid M; Awad MF; Omran A; Albalawi MA; Abdelaziz MA; Al Areefy A; Jafri I
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
    Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
    Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, α-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methylbenzimidazoles.
    Taha M; Ismail NH; Imran S; Mohamad MH; Wadood A; Rahim F; Saad SM; Rehman AU; Khan KM
    Bioorg Chem; 2016 Apr; 65():100-9. PubMed ID: 26894559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.